# About Me

Results-driven Project Manager with cross-continental experience leading pharmaceutical R&D and clinical trial projects. Proven ability to manage cross-functional teams, streamline data workflows, and drive project delivery in fast-paced, regulated environments. Skilled in Waterfall and Kanban methodologies, stakeholder communication, and risk mitigation. Demonstrated success coordinating with global teams, vendors, IT, and scientists to implement digital tools and optimize operational efficiency. Proficient in data analysis tools (Python, R). Passionate about integrating data and technology into pharma workflows to accelerate innovation and improve outcomes.

## Education
- M.S., Bioinformatics, Northeastern University, Boston, MA (_Aug 2024_) 
- M.S., Anatomy and Cell Biology, National Taiwan University, Taipei, Taiwan 
- B.S., Zoology, National Chung Hsing University, Taichung, Taiwan 

## Certification
- [Google Project Management](https://coursera.org/share/1dd7b01d7e3c647f48857737a44774aa) (Coursera)

## Skills
-	**Project Management**: Waterfall, Kanban, Jira, Risk Mitigation 
-	**Pharma Experience**: Regulatory Compliance, Clinical Trials, LIMS, Cross-functional Collaboration
-	**Technical Tools**: Python, R, SQL, Bash/Shel, Unix/Linux, High-performance computing (Slurm cluster), Git/GitHub
- **Communication**: Stakeholder Engagement, Global Team Coordination, Training Delivery

## Experience 
**Digital Transformation Intern (Project Manager) – [Boehringer Ingelheim](https://www.boehringer-ingelheim.com/), Ridgefield, CT (_May 2024 – Aug 2024_)**  
- **Coordinated cross-functional collaboration** among scientists, IT specialists, and vendors (e.g., Genedata, Certara) to streamline R&D data workflow, accelerate decision-making, and align project delivery with strategic goals.
- **Implemented lab management software** in collaboration with IT staff and engineers, optimizing account setups, data alignment, instrument integration, and automated reporting, reducing manual time, effort and errors by 90%.
- **Delivered 4 training sessions** to 80+ users across US and European teams, presenting materials and updates to drive digital tool adoption, enhance collaboration, and facilitate departmental digital transformation.
- Implemented Jira Kanban for **task tracking** across the US and Europe teams, improving task visibility and completion rates by 80%

**Data Analysis Intern – [Harvard Medical School](https://hms.harvard.edu), Boston, MA    	    				      (_June 2023 – Dec 2023_)**
- Conducted genomic analysis on lung adenocarcinoma cohorts, identifying unique mutational signatures and potential biomarkers among Taiwanese population using Python and R.
- Performed data cleaning, processing, and exploratory analysis to support the discovery of key genomic patterns relatted to LUAD.

**Associate Project Manager – Protech Pharmaservices Corporation (acquired by [Novotech](https://novotech-cro.com/contact?utm_source=Google&utm_medium=Search&utm_campaign=SN_Brand_US&utm_id=20968953014&gad_source=1&gbraid=0AAAAAqxLUiW7xn1gsbUdccQZmyOjiZxeG&gclid=Cj0KCQiA7NO7BhDsARIsADg_hIYkttxnKKJZKhrSbBtmLxXCRZLi9x85UNpQXpFXVB_tE2TrpSZlsKcaAipFEALw_wcB)), Taipei, Taiwan (_Jan 2019 – Dec 2019_)**
- **Managed** 10+ clinical trial laboratory projects, including oncology, neurology, rare disease, by spearheading **cross-functional teams** achieve project deliverables under timeframe and the budget, secure payments, increase company’s revenue.
- **Monitored Project Management Plan***, scope, timelines, and deliverables, including trend analysis of study-specific data, budget, and change orders.
- **Developed and maintained client relationships** for assigned study and served as primary liaison role between 8 Sponsors (including J&J, Daiichi Sankyo etc.,), 6 CROs, and 3 vendors, located in multiple countries for seamless study setup and conduct.
- Worked with IT teams to implement an in-house **LIMS (Laboratory Information Management System), optimizing data transformation and automating test report generation** to ensure timely review of patient reports by clinical investigators.
- **Created and maintained trial master files** to ensure all necessary documents are archived at study closure.
- **Directed biospecimen logistics & regulatory compliance**, including import/export permit applications, sample handling protocols, and data documentation, improving accuracy and reducing run time by 20-30%.
- Represented company at Sponsor Investigator Meetings and Kick-Off Meetings for **training investigators and site staff** on biospecimen workflows and lab process of clinical trials, which resulted in <5% queries in studies.
- **Streamlined biospecimen operations** by overseeing import/export permit applications and creating 3+ work instructions for study setup, data documentation, and specimen transportation, improving accuracy and reducing run time by 20-30%.
- Managed outsourced assays, resolving logistical challenges, and providing project updates to stakeholders. 

**Associate Project Manager – [Calgent Biotechnology](https://www.calgent.com/), Taipei, Taiwan (_2018_)**
- **Managed collaborations with CROs and CMOs***, ensuring GLP non-clinical study compliance and GMP production for clinical trial readiness, contributing to the regulatory pathway for multiple myeloma treatment.
- Compiled regulatory documents, including the **Investigator's Brochure**, securing orphan drug designation for a novel therapeutic.


### Preclinical Research Scientist | Biotech R& D Experience | Taipei, Taiwan | 2011 - 2016      			              	  	      
•	Led non-GLP preclinical animal studies (PK/PD/toxicity) for CNS drug candidates, optimizing protocols that accelerated IND-enabling data generation by 30%, supporting a US IND submission for acute ischemic stroke therapy (Lumosa Therapeutics).  
•	Generated efficacy data (25% tumor reduction in xenografts) supporting Advaxis partnership (FusionVax Biotechnology).

### Early-Stage Research Experience | Athens, Greece & Taipei, Taiwan | 2005 -2010
•	Investigated the role of chaperone-mediated autophagy (CMA) in Parkinson’s disease, demonstrating Lamp2a’s therapeutic potential through in vivo and in vitro models (Biomedical Research Foundation Academy of Athens).  
•	Investigated oncogene RBMY in hepatocarcinoma using in vivo models, molecular biology techniques (IHC, WB, RT-PCR), and clinical samples (National Taiwan University Hospital).  
•	Managed public facilities equipment and administrative affairs in the Anatomy Department; instructed lab sections of Gross Anatomy, Histology, and Neuroanatomy for 200+ medical and graduate students (National Taiwan University).  



## Publications
- Tsai MJ, **Peng HY**, Hsu YH. Mutational Signature Insights into Non-Smoking Female Lung Adenocarcinoma. (Manuscript in preparation)
- Kuo TH, **Peng HY**, Fu RH, Yeh SW and Wendy Huang (2016) A Novel Dual Function Molecule for the Treatment of Acute Ischemic Stroke. Stroke, (47), A173.
- Xilouri M, **Peng HY**, Stefanis L. (2012) Chaperone-mediated autophagy (CMA) in neurons. In Yue Z & Chu CT (Eds.), Autophagy of the Nervous System (pp.87 - 103), World Scientific Publishing Co.
- Xilouri M, **Peng HY**, Papasilekas T, Vekrellis K, Stefanis L (2011) Targeting the CMA pathway in neuronal cells mitigates alpha-synuclein induced toxicity. Journal of Neurochemistry, 118.
- Tsuei DJ, Lee PH, **Peng HY**, Lu HL, Su DS, Jeng YM, Hsu HC, Hsu SH, Wu JF, Ni YH, Chang MH. (2011) Male germ cell-specific RNA binding protein RBMY: A new oncogene explaining male predominance in liver cancer. PLoS ONE, 6 (11), e26948.
